Dr. Julie Gralow, Executive Vice President and Chief Medical Officer of ASCO (American Society of Medical Oncology,) the largest society for oncologists around the world, shares her career journey until she assumed the post of ASCO-CMO during the COVID-19 pandemic.
Julie is a pioneer in global oncology and a world-renowned leader in breast cancer, being an innovator and a researcher at the Fred Hutchinson Cancer Center in Seattle for over 20 years. Her impact on the field is second to none.
Dr. Gralow discusses how ASCO attempts to address hot and controversial issues in oncology in a timely and effective manner. We go over the current chemotherapy shortage and abortion rights for patients with cancer, among other topics.
This episode is a must-listen for everyone in oncology; hear the most influential medical voice in oncology on behalf of our society and be inspired.
View “A Day in the Life” of Dr. Gralow at the ASCO Annual Meeting: https://twitter.com/asco/status/1671578875145461774
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
